Atlas Trials

Study of First Line Treatment of Chronic Graft Versus Host Disease With the Association of Ciclosporine, Corticosteroids and Rituximab (Protocol R-GVHD)

Clinical trial NCT01135641 · COMPLETED

Trial details

NCT number
NCT01135641
Sponsor
Nantes University Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Graft Versus Host Disease
Start date
2010-06-01
Primary completion
2014-03-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.